The Latest Breaking News from Alzheimer Disease

As the world population has grown older, Alzheimer’s disease has become increasingly common. Alzheimer’s disease is the most prevalent form of dementia. Dementia is a term used to describe a range of symptoms linked to the decline in brain function with age. Symptoms include memory loss, communication difficulties, problem-solving struggles,…

The number of people with dementia, including those with Alzheimer's disease, are projected to increase from 50+ million now to more than 150 million in 2050, according to Alzheimer's Disease International. Those sheer numbers will mean that investors in certain stocks, producing Alzheimer's drugs to combat the disease, are poised…

Rare genetic resilience to the disease has been identified in a second patient

In a new study, researchers identified a rare gene mutation that may offer resiliency against Alzheimer's disease.

Researchers suggest the findings could open a door for the prevention and treatment of incurable diseases.

According to a study from the University of California, Irvine, exposure to traffic-related air pollution causes memory loss, cognitive decline, and the activation of brain pathways linked to the onset of Alzheimer's disease. Read further on Dynamite News:

Donanemab was shown in a late-stage trial to slow cognitive decline more than a third

American pharmaceutical company Eli Lilly announced last week that it had seen encouraging clinical trial results of its new Alzheimer’s medication. According to the company, their experimental drug, donanemab, was shown in a late-stage trial to slow cognitive decline by 35%. While these results do sound promising, the full data…

Almost half of those on donanemab had no clinical progression of disease at one year compared with 29% on a placebo, a study showed.